FDA Clearance Tracker · K253761
HydroMARK Plus Breast Biopsy Site Marker (Dragonfly Shape); HydroMARK Plus Breast Biopsy Site Marker (Hummingbird Shape)
Last checked: Nov 20, 2026Latest source record: Jan 23, 2026 (this decision)Source: openFDAMethods & limitations
Decided
Jan 23, 2026
Substantially Equivalent
Time to decision
59 days
Received Nov 25, 2025. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K253761
- Device name
- HydroMARK Plus Breast Biopsy Site Marker (Dragonfly Shape); HydroMARK Plus Breast Biopsy Site Marker (Hummingbird Shape)
- Applicant
- Devicor Medical Products, Inc.
- Applicant location
- Cincinnati, OH
- Received
- Nov 25, 2025
- Decided
- Jan 23, 2026
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device type
- Marker, Radiographic, Implantable (NEU)
- Device class
- Class II
- Regulation
- 21 CFR 878.4300
- Specialty
- General & Plastic Surgery
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code NEU. The earliest in FDA's data is K010348, decided May 3, 2001.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K253761
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Devicor Medical Products, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K260365 · Decided Mar 4, 2026 · 28 days after receipt
Device type: Instrument, Biopsy (KNW) · GI, Urology & Nephrology
- Mammotome AutoCore Single Insertion Core Biopsy SystemThird-party review510(k)
K243095 · Decided Oct 29, 2024 · 29 days after receipt
Device type: Instrument, Biopsy (KNW) · GI, Urology & Nephrology
K240527 · Decided Jul 10, 2024 · 138 days after receipt
Device type: Marker, Radiographic, Implantable (NEU) · General & Plastic Surgery
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.